1. AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Why did the KAM TD jump ship?

Discussion in 'Exact Sciences' started by anonymous, Jan 12, 2016 at 3:41 PM.

  1. anonymous

    anonymous Guest

    Is something happening that reps don't know about?